Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion

Matrix Biology

Volumn 17, Issue 7, 1998, Pages 485-493

  Lyon, Malcolm ^a   Gallagher, John T ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GROWTH FACTOR; HEPARAN SULFATE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

BINDING SITE; CELL ADHESION; CELL GROWTH; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SKIN FIBROBLAST;

EID: 0031650702     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90096-8     Document Type: Short Survey

References (50)

1. Archer, S.J., Bax, A., Roberts, A.B., Sporn, M.B., Ogawa, Y., Piez, K.A., Weatherbee, J.A.,Tsang, M.L-S., Lucas, R., Zheng, B-L., Wenker, J. and Torchia, D.A.: Transforming growth factor-β1. Secondary structure as determined by heteronuclear magnetic resonancespectroscopy. Biochemistry 32: 1164-1171, 1993.
2. Barkalow, F.J.B. and Schwarzbauer, J.E.: Localization of the major heparin-binding site in fibronectin. J.Biol. Chem. 266: 7812-7818, 1991.
3. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.C. and Lose, E.: Biology of the syndecans. A family of transmembrane heparan sulphate proteoglycans. Ann. Rev.Cell Biol. 8: 365-393, 1992.
4. Brickman, Y.G., Ford, M.D., Gallagher, J.T., Nurcombe, V., Bartlett, P.P. and Turnbull, J.E.: Structural modification of fibroblast growth factor- binding heparan sulphate at a determinative stage of neural development. J. Biol. Chem. 273: 4350-4359, 1998.
5. Busby, T.F., Argraves, W.S., Brew, S.A., Pechik, I., Gilliland, G.L. and Ingham, K.C.: Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J. Biol. Chem. 270: 18558-18562, 1995.
6. Dickinson, C.D., Veerapandian, B., Dai, X.-P., Hamlin, R.C., Xuong, N.-H., Ruoslahti, E. and Ely, K.R.: Crystal structure of the tenth type III cell adhesion module of human fibronectin. J. Mol. Biol. 236: 1079-1092, 1994.
7. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J. and Rees, D.C.: Heparin structure and interactions with basic fibroblast growth factor. Science 271: 1116-1120, 1996.
8. Fromm, J.R., Hileman, R.E., Caldwell, E.E.O., Weller, J.M. and Linhardt, R.J.: Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 323: 279-287, 1995.
9. Gallagher, J.T.: The interaction and regulation of basic and acidic fibroblast growth factors by heparan sulphate. T.I.G.G. 10: 137-144, 1998.
10. Gallagher, J.T., Turnbull, J.E. and Lyon, M.: Patterns of sulphation in heparan sulphate. Polymorphism based on a common structural theme. Int. J. Biochem. 24: 553-560, 1992.
11. Guimond, S., Maccarana, M., Olwin, B.B., Lindahl, U. and Rapraeger, A.C.: Activating and inhibiting heparin sequences for FGF-2 (basic FGF). J. Biol. Chem. 268: 23906-23914, 1993.
12. Harper, J.W. and Lobb, R.R.: Reductive methylation of lysine residues in acidic fibroblast growth factor. Effect on mitogenic activity and heparin affinity. Biochemistry 27: 671-678, 1988.
13. Hartmann, G., Prospero, T., Brinkmann, V., Ozcelik, O., Winter, G., Hepple, J., Batley, S., Bladt, F., Sachs, M., Birchmeier, C., Birchmeier, W. and Gherardi, E.: Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8: 125-134, 1997.
14. Herr, A.B., Ornitz, D.M., Sasisekharan, R., Venkataraman, G. and Waksman, G.: Heparin-induced self-association of fibroblast growth factor-2. J. Biol. Chem. 272: 16382-16389, 1997.
15. Ingham, K.C., Brew, S.A. and Atha, D.H.: Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem. J. 272: 605-611, 1990.
16. Ingham, K.C., Brew, S.A., Migliorini, M.M. and Busby, T.F.: Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin. Biochem. J. 32: 12548-12553, 1993.
17. Ishihara, M.: Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. Glycobiology 4: 817-824, 1994.
18. Ishihara, M. and Ono, K.: Structure and function of heparin and heparan sulphate. Heparinoid library and modification of FGF activities. T.I.G.G. 10: 223-233, 1998.
19. Kan, M., Wang, F., Kan, M., To, B., Gabriel, J.L. and McKeehan, W.L.: Divalent cations and heparin/heparan sulphate cooperate to control assembly and activity of the fibroblast growth factor-receptor complex. J. Biol. Chem. 271: 26143-26148, 1996.
20. Kjellén, L. and Lindahl, U.: Proteoglycans - structure and interactions. Annu. Rev. Biochem. 60: 443-476, 1991.
21. Lobb, R.R. : Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 27: 2572-2578, 1988.
22. Lyon, M., Deakin, J.A. and Gallagher, J.T.: Liver heparan sulphate structure. A novel molecular design. J. Biol. Chem. 269: 11208-11215, 1994a.
23. Lyon, M., Deakin, J.A., Mizuno, K., Nakamura, T. and Gallagher, J.T.: Interaction of hepatocyte growth factor with heparan sulphate. Elucidation of the major heparan sulphate structural determinants. J. Biol. Chem. 269: 11216-11223, 1994b.
24. Lyon, M., Deakin, J.A., Rahmoune, H., Fernig, D.G., Nakamura, T. and Gallagher, J.T.: Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulphate. J. biol. Chem. 273: 271-278, 1998.
25. Lyon, M., Rushton, G. and Gallagher, J.T.: The interaction of the transforming growth factor-βs with heparin/heparan sulphate is isoform-specific. J. Biol. Chem. 272: 18000-18006, 1997.
26. Lyon, M., Steward, W.P., Hampson, I.N. and Gallagher, J.T.: Identification of an extended N-acetylated sequence adjacent to the protein linkage region of fibroblast heparan sulphate. Biochem. J. 242: 493-498, 1987.
27. Maccarana, M., Casu, B. and Lindahl, U.: Minimal sequence in heparin/heparan sulphate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268: 23898-23905, 1993.
28. Maccarana, M., Sakara, Y., Tawada, A., Yoshida, K. and Lindahl, U.: Domain structure of heparan sulphate from bovine organs. J. Biol. Chem. 271: 17804-17810, 1996.
29. McCaffrey, T.A., Falcone, D.J. and Du, B.: Transforming growth factor-β1 is a heparin-binding protein. Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J. Cell Physiol. 152: 430-440, 1992.
30. Mizuno, K., Inoue, H., Hagiya, M., Shimizu, S., Nose, T., Shimohigashi, Y. and Nakamura, T.: Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269: 1131-1136, 1994.
31. Moy, F.J., Safran, M., Seddon, A.P., Kitchen, D., Bohlen, P., Aviezer, D., Yayon, A. and Powers, R.: Properly oriented heparin decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Biochemistry 36: 4782-4791, 1997.
32. Nugent, M.A. and Edelman, E.R.: Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulphate proteoglycan - a mechanism for co-operativity. Biochemistry 31: 8876-8883, 1992.
33. Nurcombe, V., Ford, M.D., Wildschut, J.A. and Bartlett, P.F.: Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulphate proteoglycan. Science 260: 103-106, 1993.
34. Pye, D.A., Vives, R., Turnbull, J.E., Hyde, P. and Gallagher, J.T.: Heparan sulphate oligosaccharides require 6-O-sulphation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem. 273(36): 22936-22942, 1998.
35. Rahmoune, H., Chen, H.-L., Gallagher, J.T., Rudland, P.S. and Fernig, D.G.: Interaction of heparan sulphate from mammary cells with acidic fibroblast growth factor (aFGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites heparan sulphate. J. Biol. Chem. 273: 7303-7310, 1998a.
36. Rahmoune, H., Gallagher, J.T., Rudland, P.S. and Fernig, D.G.: Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulphate from mammary cells. Biochemistry 37: 6003-6008, 1998b.
37. Sakata, H., Stahl, S.J., Taylor W.G., Rosenberg, J.M., Sakaguchi, K., Wingfield, P.T. and Rubin, J.S.: Heparin binding and oligomerization of hepatocyte growth factor/scatter f factor isoforms. Heparan sulphate glycosaminoglycan requirement for Met binding and signalling. J. Biol. Chem. 272: 9457-9463, 1997.
38. Schlunegger, M.P. and Grütter, M.G.: An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-β2. Nature 358: 430-434, 1992.
39. Springer, B.A., Pantoliano, M.W., Barbera, F.A., Gunyuzlu, P.L., Thompson, L.D., Herblin, W.F., Rosenfeld, S.A. and Book, G.W.: Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269: 26879-26884, 1994.
40. Thompson, L.D., Pantoliano, M.W. and Springer, B.A.: Energetic characterization of the basic fibroblast growth factorheparin interaction. Identification of the heparin-binding domain. Biochemistry 33: 3831-3840, 1994.
41. Turnbull, J.E., Fernig, D.F., Ke, Y., Wilkinson, M.C. and Gallagher, J.T.: Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulphate. J. Biol. Chem. 267: 10337-10341, 1992.
42. Turnbull, J.E. and Gallagher, J.T.: Sequence analysis of heparan sulphate indicates defined locations of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein linkage region. Biochem. J. 277: 297-303, 1991.
43. Van den Born, J., Gunnarsson, K., Bakker, M.A.H., Kjellén, L., Kusche-Gullberg, M., Maccarana, M., Berden, J.H.M. and Lindahl, U.: Presence of N-unsubstituted glucosamine units in native heparan sulphate revealed by a monoclonal antibody. J. Biol. Chem. 270: 31303-31309, 1995.
44. Veugelers, M. and David, G.: The glypicans - a family of GPI-anchored heparan sulphate proteoglycans with a potential role in the control of cell division. T.I.G.G. 10: 145-152, 1998.
45. Walker, A. and Gallagher, J.T.: Structural domains of heparan sulphate for specific recognition of the C-terminal heparinbinding domain of human plasma fibronectin (Hep II). Biochem. J. 317: 871-877, 1996.
46. Walker, A., Turnbull, J.E. and Gallagher, J.T.: Specific heparan sulphate saccharides mediate the activity of basic fibroblast growth factor. J. Biol. Chem. 269: 931-935, 1994.
47. Wang, H., Toida, T., Kim, Y.S., Capila, I., Hileman, R.E., Bernfield, M. and Linhardt, R.J.: Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Biochem. Biophys. Res. Commun. 235: 369-373, 1997.
48. Woods, A., McCarthy, J.B., Furcht, L.T. and Couchman, J.R.: A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell 4: 605-613, 1993.
49. Zhou, H., Mazzulla, D.P. and Byrd, R.A.: The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Structure 6: 109-116, 1998.
50. Zioncheck, T.F., Richardson, L., Liu, J., Chang, L., King, K.L., Bennett, G.L., Fügedi, P.,Chamow, S.M., Schwall, R.H. and Stack, R.J.: Sulphated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270: 16871-16878, 1995.